News

Access and download our newsletters from the Newsletter Archive

 
 

As well as keeping you up to date with the latest developments within the life sciences sector, Bionow members can also post updates to the Bionow News page to promote themselves to over 300 Bionow member organisations and the UK Life Sciences sector.

Whether currently a member or not, keep up to date with all the latest news and events by registering to receive the Bionow newsletter.

The University of Liverpool has launched a new spin-out company, TrophiCell, that has developed a revolutionary approach to harness the therapeutic potential of adult Mesenchymal Stem Cells ...

Clinical Trial Authorisation application granted for combined drug PK051 targeting amyloid deposits associated with Alzheimer’s Disease

The experienced life science logistics company, Biocair, provides critical logistics support to a cutting-edge research project into drugs that can treat, and prevent, one of the world’s m...

PharmaKure submits MHRA CTA for Phase 2a Clinical Trial of PK051 in patients with mild cognitive impairment Clinical Trial Application filed for combined drug targeting amyloid deposits as...

Iksuda Therapeutics announces first patient dosed in Phase 1 trial of IKS014 in patients with advanced solid tumours that express HER2

Stopping memory loss: how to use AI to diagnose and treat dementia early.

Christopher Good, Director of Cell and Gene Therapy Logistics at Biocair, reflects on his last two decades with the company and how the industry has changed during that time.

The “Flight Simulator for healthcare and life sciences” addresses staffing pressures, continuous learning demands and the pace of innovation in life sciences

With approval of MHRA to submit a CTA, PharmaKure is now well positioned to advance towards its clinical trial programme that is essential to market authorisation

Two years into the pandemic, we consider its impact on the life science sector and how the risk landscape is evolving as the industry builds on the progress it has made.

Immundnz has recently installed a new flow cytometer and launched a new website

In Silico trials offer great potential savings in time and money. However, they are not without challenges. Are you developing an In Silico model, or are in the process of using one or have...

Sign up to our Newsletter

Subscribe

* indicates required

Our Valued Sponsors & Partners